AIN
Albany International Corp.
AIN offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
AMZN
Amazon.com, Inc.
AMZN has the edge over AIN overall, supported by stronger modeled upside and stronger valuation.
AIN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Stable | |
| Healthy |
AIN's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
AIN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 21x | $66.39 | -1.8% |
| Current | 21x | $67.58 | — |
| Forward | 23x | $67.58 | — |
| Fair | 25x | $77.69 | +15% |
| Expensive | 30x | $93.70 | +39% |
Historical ranges are pointers, not guarantees.
AIN's PE is in its cheap range at 21x. Analysts expect earnings to fall, which would put today's price at 23x next year's earnings.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over AIN in the historical PE scenario, which offers more potential upside but is not a forecast.
AIN Forward outlook
| Metric | Outlook |
|---|---|
| Deteriorating | |
| Decline | |
| Growth | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect AIN's revenue to grow, but its earnings and profitability to decline.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
AMZN has the edge over AIN on the outlook, with more favorable earnings and profitability expectations.
AIN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.99 | -5.6% |
| Q3 2026 | $3.17 | +$5.10 |
| Q2 2026 | -$1.66 | -183% |
| Q1 2026 | -$1.96 | -179% |
| Q4 2025 | -$1.94 | -169% |
| Q3 2025 | -$1.93 | -160% |
| Q2 2025 | $2.01 | -43% |
| Q1 2025 | $2.49 | -30% |
| Q4 2024 | $2.80 | -21% |
AIN has returned to profit: it earned $3.17 per share over the past year, after losing money the year before.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over AIN on earnings, with more consistent year-over-year improvement.
AIN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $349.5M | +34% |
| Q2 2026 | $329.5M | +5.8% |
| Q1 2026 | $311.3M | +7.8% |
| Q4 2025 | $321.2M | +12% |
| Q3 2025 | $261.4M | -12% |
| Q2 2025 | $311.4M | -6.2% |
| Q1 2025 | $288.8M | -7.8% |
| Q4 2024 | $286.9M | -11% |
AIN's revenue has grown year over year for four quarters in a row: $350M last quarter, up 34% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 17% | +62 points |
| Q2 2026 | 9.8% | +2.6 points |
| Q1 2026 | 8.2% | -1.6 points |
| Q4 2025 | 9.3% | +0.8 points |
| Q3 2025 | -45% | -53 points |
| Q2 2025 | 7.2% | -5.8 points |
| Q1 2025 | 9.8% | -2.7 points |
| Q4 2024 | 8.5% | -4.4 points |
AIN has the edge over AMZN on profitability, with a higher operating margin.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over AIN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN's operating margin was 14% last quarter, up 4.2 points from the same quarter a year ago, near the top of its range since 2019.
AIN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $36.5M | +41% |
| Q2 2026 | -$14.5M | -177% |
| Q1 2026 | -$3.6M | +$9.8M |
| Q4 2025 | $51.4M | -15% |
| Q3 2025 | $25.9M | -18% |
| Q2 2025 | $18.8M | -70% |
| Q1 2025 | -$13.5M | +$3.8M |
| Q4 2024 | $60.2M | +52% |
AIN has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
AIN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +8K shares |
| 1 year | -1.4% | -416K shares |
| 3 years | -8.6% | -2.7M shares |
| 5 years | -12% | -3.8M shares |
| Available history | -12% | -3.7M shares |
AIN has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $15M |
| Q3 2025 | $50.5M |
| Q2 2025 | $51.3M |
| Q1 2025 | $69.2M |
| Q4 2023 | — |
AIN spent $15M buying back its own shares over the past year.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
AIN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.5x | Healthy |
| Q2 2026 | 7.5x | High |
| Q1 2026 | 7.9x | High |
| Q4 2025 | 6.6x | High |
| Q3 2025 | 8.2x | High |
| Q2 2025 | 1.8x | Healthy |
| Q1 2025 | 1.4x | Healthy |
| Q4 2024 | 0.9x | Very low |
AIN's net debt is about 1.5 years of its operating earnings (EBITDA), down from 8.2 years a year ago.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over AIN on leverage, with a lower net debt burden relative to earnings.
AIN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.0 | Neutral |
| Stochastic | 58.9 | Neutral |
AIN's weekly RSI is 57 (neutral) and its Stochastic is 59 (neutral).
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
AIN PE vs Consumer Cyclical Sector
| Metric | AIN | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 18x | 18% above |
| PE % | 19 | 47 | 28 pts below |
AIN has the edge over AMZN on valuation relative to its sector.
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
AIN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $63.6 | 6.2% above |
| 20 week MA | $65.4 | 3.3% above |
| 50 week MA | $61.1 | 11% above |
| 100 week MA | $63.7 | 6.1% above |
| 200 week MA | $76.5 | 12% below |
AIN has bounced recently, but its long-term trend is still down: it's above its 8-, 20-, 50- and 100-week averages, but 12% below its 200-week average.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over AIN on trend strength, trading above more of its moving averages.
AIN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $76.5 | $73.1 | -4.5% |
| 2021 | $73.1 | $88.5 | +21% |
| 2022 | $88.5 | $98.7 | +11% |
| 2023 | $98.7 | $98.2 | -0.5% |
| 2024 | $98.2 | $80.1 | -18% |
| 2025 | $80.1 | $51.6 | -36% |
| 2026 YTD | $51.6 | $67.6 | +31% |
AIN has the edge over AMZN on returns for 2026, with the stronger performance.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has finished higher in five of the last six years, two of them by more than 50%. It's up 15% so far in 2026.